Quanterix (QTRX) Total Current Liabilities (2017 - 2026)
Quanterix (QTRX) posted Total Current Liabilities of $49.9 million for Q1 2026, down 33.25% on a QoQ basis from $74.8 million in Q4 2025, and up 23.54% year-over-year from $40.4 million in Q1 2025.
Quanterix (QTRX) Total Current Liabilities (2017 - 2026) Analysis & Trends
Quanterix's Total Current Liabilities history runs 10 years deep, the most recent figure standing at $49.9 million for Q1 2026.
- Quarterly Total Current Liabilities rose 23.54% year-over-year to $49.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.9 million (up 23.54% YoY) and the FY2025 annual result came in at $74.8 million, up 77.98% from the prior year.
- Total Current Liabilities was $49.9 million for Q1 2026 at Quanterix, down from $74.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $77.4 million in Q3 2025 and bottomed at $27.5 million in Q1 2023.
- A 5-year average of $41.4 million and a median of $36.7 million in 2022 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities decreased 15.22% — and 2025, when it soared 112.19%.
- Quanterix's Total Current Liabilities stood at $31.3 million in 2022, then advanced by 24.35% to $39.0 million in 2023, then advanced by 7.76% to $42.0 million in 2024, then soared by 77.98% to $74.8 million in 2025, then sank by 33.25% to $49.9 million in 2026.
- Business Quant data shows QTRX's Total Current Liabilities at $49.9 million in Q1 2026, $74.8 million in Q4 2025, and $77.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | 49.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.91 Mn |
| Dec 31, 2025 | 74.76 Mn |
| Sep 30, 2025 | 77.35 Mn |
| Jun 30, 2025 | 48.20 Mn |
| Mar 31, 2025 | 40.40 Mn |
| Dec 31, 2024 | 42.01 Mn |
| Sep 30, 2024 | 36.45 Mn |
| Jun 30, 2024 | 38.14 Mn |
| Mar 31, 2024 | 32.76 Mn |
| Dec 31, 2023 | 38.98 Mn |
| Sep 30, 2023 | 35.90 Mn |
| Jun 30, 2023 | 32.61 Mn |
| Mar 31, 2023 | 27.48 Mn |
| Dec 31, 2022 | 31.35 Mn |
| Sep 30, 2022 | 28.92 Mn |
| Jun 30, 2022 | 36.73 Mn |
| Mar 31, 2022 | 31.76 Mn |
| Dec 31, 2021 | 36.98 Mn |
| Sep 30, 2021 | 31.19 Mn |
| Jun 30, 2021 | 37.68 Mn |